GSP
LIVE

Serial Number

79378326

Owner

Wallac Oy

Attorney

Carrie Webb Olson

Filing Date

Aug 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GSP Trademark

Serial Number: 79378326 • Registration: 7726050

GSP is a trademark filed by Wallac Oy on August 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Wallac Oy

Mustionkatu 6
Turku 20750 , FI

Entity Type: 99

Trademark Details

Filing Date

August 4, 2023

Registration Date

March 18, 2025

Published for Opposition

January 28, 2025

Goods & Services

Medical and veterinary apparatus and instruments, namely, blood testing apparatus; analytical instruments for screening disorders in newborns based on blood samples for medical use; blood testing apparatus for use in medical analysis; genetic testing apparatus for carrying-out diagnostic tests for medical purposes; diagnostic instruments for detecting genetic predispositions for use in medical analysis; diagnostic apparatus for detecting genetic predispositions and screening disorders in newborns based on blood samples for medical purposes; diagnostic instruments for the analysis of body fluids for medical use; medical diagnostic apparatus for the analysis of body fluids for medical purposes; medical diagnostic instruments for the analysis of body fluids; testing instruments for the analysis of body fluids for medical diagnostic purposes; medical diagnostic testing apparatus for the analysis of body fluids for use in immunoassay procedures; medical diagnostic testing instruments for detecting genetic predispositions for use in immunoassay procedure; diagnostic imaging apparatus for medical use; medical imaging apparatus; automated analyzers for body fluids for medical use

Diagnostic reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for medical use; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; immunoassay reagents for medical use; enzyme preparations for medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 18, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 25, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 25, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 18, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 8, 2025 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2024 CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2024 TROA
REFUSAL PROCESSED BY IB
May 22, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 15, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 12, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2023 REPR